Pulmonx Reports First Quarter 2024 Financial Results
May 01, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
April 10, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 02, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024 17:00 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024 16:06 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
February 21, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
February 07, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Participate at Upcoming Investor Conferences
October 31, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Record Third Quarter 2023 Financial Results
October 30, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...